NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 231 filers reported holding NEVRO CORP in Q4 2020. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,573 | -23.3% | 342 | +1.5% | 0.00% | – |
| Q2 2023 | $8,567 | +23697.2% | 337 | -66.0% | 0.00% | – |
| Q1 2023 | $36 | -23.4% | 990 | -17.2% | 0.00% | – |
| Q4 2022 | $47 | -99.9% | 1,195 | 0.0% | 0.00% | – |
| Q3 2022 | $46,000 | -9.8% | 1,195 | +2.1% | 0.00% | – |
| Q2 2022 | $51,000 | -23.9% | 1,170 | +27.2% | 0.00% | – |
| Q1 2022 | $67,000 | +123.3% | 920 | +104.4% | 0.00% | – |
| Q4 2021 | $30,000 | -80.9% | 450 | -66.7% | 0.00% | -100.0% |
| Q3 2021 | $157,000 | +5.4% | 1,350 | +50.0% | 0.00% | 0.0% |
| Q2 2021 | $149,000 | -14.4% | 900 | -28.0% | 0.00% | 0.0% |
| Q1 2021 | $174,000 | -19.4% | 1,250 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $216,000 | +41.2% | 1,250 | +13.6% | 0.00% | 0.0% |
| Q3 2020 | $153,000 | +325.0% | 1,100 | +266.7% | 0.00% | – |
| Q2 2020 | $36,000 | +38.5% | 300 | +15.4% | 0.00% | – |
| Q1 2020 | $26,000 | -25.7% | 260 | -13.3% | 0.00% | – |
| Q4 2019 | $35,000 | +150.0% | 300 | +87.5% | 0.00% | – |
| Q3 2019 | $14,000 | +40.0% | 160 | 0.0% | 0.00% | – |
| Q2 2019 | $10,000 | 0.0% | 160 | 0.0% | 0.00% | – |
| Q1 2019 | $10,000 | +66.7% | 160 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | -33.3% | 160 | 0.0% | 0.00% | – |
| Q3 2018 | $9,000 | -30.8% | 160 | 0.0% | 0.00% | – |
| Q2 2018 | $13,000 | -7.1% | 160 | 0.0% | 0.00% | – |
| Q1 2018 | $14,000 | +27.3% | 160 | 0.0% | 0.00% | – |
| Q4 2017 | $11,000 | -26.7% | 160 | 0.0% | 0.00% | – |
| Q3 2017 | $15,000 | +25.0% | 160 | 0.0% | 0.00% | – |
| Q2 2017 | $12,000 | -20.0% | 160 | 0.0% | 0.00% | – |
| Q1 2017 | $15,000 | -31.8% | 160 | -46.7% | 0.00% | – |
| Q4 2016 | $22,000 | – | 300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tiger Eye Capital LLC | 239,122 | $41,392,000 | 8.25% |
| Integral Health Asset Management, LLC | 88,000 | $15,233,000 | 4.53% |
| Iron Triangle Partners LP | 168,761 | $29,213,000 | 3.79% |
| Eos Focused Equity Management, L.P. | 14,002 | $2,424,000 | 2.37% |
| PFM Health Sciences, LP | 311,940 | $53,997,000 | 1.90% |
| Perceptive Advisors | 977,565 | $169,217,000 | 1.82% |
| Rock Springs Capital Management LP | 395,000 | $68,375,000 | 1.45% |
| Lisanti Capital Growth, LLC | 54,302 | $9,400,000 | 1.30% |
| HealthCor Management, L.P. | 156,046 | $27,012,000 | 1.04% |
| FRED ALGER MANAGEMENT, LLC | 2,136,612 | $369,848,000 | 0.96% |